REALITY
In patients with acute myocardial infarction and anaemia is a restrictive, compared with a liberal transfusion strategy, non-inferior with respect to major adverse cardiovascular outcomes at 30 days?
Continue reading »Tag: Haematology
PlasmAr
es convalescent plasma compared with placebo, improve patients’ clinical status at 30 days?
Continue reading »ITACTIC
In adult trauma patients presenting with signs of haemorrhagic shock does the utilisation of a viscoelastic haemostatic assay (VHA) augmented transfusion strategy compared to a strategy augmented by conventional coagulation tests (CCT) result in an increased number of patients alive and free of massive transfusion at 24 hours?
Continue reading »HERCULES
In patients with acquired thrombocytopenia purport, does calpacizumab compared with placebo, reduce the time to normalisation of the platelet count?
Continue reading »PATCH
In patients with acute intracerebral haemorrhage, associated with antiplatelet therapy, does platelet transfusion compared with standard care reduce death or dependence?
Continue reading »